Home
Resources
Publications
Quercetin-3-oleoyl Derivatives as New GPR40 Agonists: Molecular Docking Studies and Functional Evaluation

Quercetin-3-oleoyl Derivatives as New GPR40 Agonists: Molecular Docking Studies and Functional Evaluation

Gabriele Carullo, Mariarita Perri, Fabrizio Manetti, Francesca Aiello, Maria Cristina Caroleo, Erika Cione

Bioorg Med Chem Lett. 2019 Jul 15;29(14):1761-1764.

PMID: 31104992

Abstract:

The G-protein-coupled receptor 40 (GPR40) is an attractive molecular target for the treatment of type 2 diabetes mellitus. Previously, based on the natural oleic acid substrate, an exogenous ligand for this receptor, named AV1, was synthesized. In this context, here we validated the activity of AV1 as a full agonist, while the corresponding catechol analogue, named AV2, was investigated for the first time. The ligand-protein interaction between this new molecule and the receptor was highlighted in the lower portion of the GPR40 groove that generally accommodates DC260126. The functional assays performed have demonstrated that AV2 is a suitable GPR40 partial agonist, showing a therapeutic potential and representing a useful tool in the management of type 2 diabetes.

Chemicals Related in the Paper:

Catalog Number	Product Name	Structure	CAS Number	Price
AP346692044	DC260126		346692-04-4	Price

As a specialist in analytical chemical Products, Alfa Chemistry offers consumers a wealth of raw materials and a full range of technologies and services.

QUICK LINKS

HEADQUARTERS

Tel:

Fax:

Email: